How many clicks does 2.5 mg Mounjaro take from a 15 mg pen?

Why does a 2.5 mg dose take only two clicks on a 15 mg pen, but a different number on other pens?

The Mounjaro KwikPen range is not a single device scaled up. Each pen strength has its own concentration and its own click increment, which is why the click count for the same dose varies depending on the pen you are using. On the 15 mg pen, Eli Lilly set the increment at 1.25 mg per click. Two clicks lands you precisely on 2.5 mg, as confirmed by the dose counter window on the side of the pen before you inject.

On lower-strength pens the increment is smaller. If you have moved through the titration schedule and are curious how the arithmetic works for earlier pens, the mechanics for the 2.5 mg dose from a 5 mg pen follow a different click-per-mg ratio, because the concentration is different. The same logic applies to the 2.5 mg dose from a 10 mg pen. The pen does the maths; the counter shows you the result. Your job is to confirm it before pressing.

This matters more than it might sound. Using a pen from one part of the titration schedule when you are actually supposed to be on a different strength can lead to either under-dosing or over-dosing. Your prescriber specifies not only the dose in milligrams but the pen strength to use at each stage, and if you are stepping up to a 7.5 mg pen it is worth checking how many clicks are needed for a 5 mg dose from the 7.5 mg pen, because the increment differs from what you may be used to. If there is ever a mismatch between the pen you have received and the dose on your prescription, contact your pharmacy before injecting.

What does the dose counter actually show, and how do you know you have clicked correctly?

Before you press the injection button, the dose counter on the 15 mg KwikPen will read 2.5 after two clicks. That number is your confirmation. Eli Lilly built the counter specifically so you can verify the dose visually rather than relying on counting clicks alone. The NHS patient information for tirzepatide, available via the NHS medicines page for tirzepatide, points patients to the leaflet inside the box for step-by-step injection guidance, including how to read the counter correctly.

A few things can cause confusion. If the counter does not move after a click, the pen cap may not have been removed fully, or the pen may not be primed. Priming is done before the very first use of a new pen (one click to release any air) but from the second dose onward on the same pen, you dial straight to your prescribed dose without re-priming. If you are unsure, the Patient Information Leaflet in the box is the definitive reference. Your prescriber or pharmacist can also talk you through it. Do not inject if the dose counter does not display the expected number.

For context on the total number of doses held in a single 15 mg pen, the full click and dose breakdown for the 15 mg pen covers how each pen's four doses are divided across a four-week supply.

Does being on the 15 mg pen at the 2.5 mg setting mean anything is wrong?

Not at all. There are a few legitimate clinical situations where someone uses a higher-strength pen at a lower dose. The most common is a supply situation: if the 2.5 mg pen is temporarily unavailable, a prescriber may authorise use of a different pen strength at the equivalent dose. This is a prescriber decision, not something to arrange independently, and it requires explicit instruction because the click count changes.

If your prescription was written for a specific pen strength and that is what you received, you are in the right place. The 2.5 mg starting dose is designed to give your body time to adjust before stepping up. It is not a therapeutic plateau; it is a settling-in period, typically lasting around four weeks before your prescriber considers moving you forward. For a broader picture of how that progression works, the Mounjaro treatment overview covers the full licensed schedule factually. Cost questions that sometimes arise during the titration journey are addressed on the Mounjaro pricing page.

The NICE appraisal of tirzepatide (TA1026) confirmed the treatment's clinical evidence base, and the NICE TA1026 recommendations set out the conditions under which tirzepatide is recommended. Your prescriber works within that evidence base when deciding your dose and schedule.

What should you do if you have clicked the wrong number of times?

If you have clicked past 2.5 mg and the counter shows a higher number, do not inject. On most KwikPen designs the dose can be corrected by clicking back down to the correct setting before the injection button is pressed — but check the Patient Information Leaflet first, because the exact correction method is pen-generation-specific and the leaflet is the authoritative source for your device.

If you have already injected more than your prescribed dose, contact your prescriber or call NHS 111 for advice. Tirzepatide side effects are dose-related, so a larger-than-intended dose increases the likelihood of gastrointestinal discomfort, particularly nausea. Do not attempt to compensate by skipping the next scheduled injection without clinical guidance.

Questions about what happens at different dose steps are something our prescribers field regularly. If you are mid-titration and uncertain about anything (a missed dose, a pen that looked different from the last batch, a week where you ordered just after the Monday cut-off before a bank holiday) the right step is always to ask before you inject. The frequently asked questions page covers many common mid-treatment queries, and the contact page connects you to our aftercare team. For anyone considering starting treatment and wondering how the process works, checking your eligibility is the first step.